Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cindy Neuzillet

Showing results (41-50 of 138) with videos related to

Pageof 14
Sort By:
Clinics and Research in Hepatology and Gastroenterology|June 26, 2023
Nutrition support in pancreatic cancer: An expert statement on practical implementation of French guidelinesJulien Taieb, Raëf Abdallah, Ronan Thibault, et al.
Clinics and Research in Hepatology and Gastroenterology|February 19, 2021
Microbiome and pancreatic ductal adenocarcinomaAnnemilaï Tijeras-Raballand, Marc Hilmi, Lucile Astorgues-Xerri, et al.
Oncotarget|July 13, 2015
Targeting cancer cell metabolism in pancreatic adenocarcinomaRomain Cohen, Cindy Neuzillet, Annemilaï Tijeras-Raballand, et al.
Medicine|July 2, 2016
Severe hyponatremia caused by nab-paclitaxel-induced syndrome of inappropriate antidiuretic hormone secretion: A case report in a patient with metastatic pancreatic adenocarcinomaCindy Neuzillet, Samy Babai, Emmanuelle Kempf, et al.
Pharmacology & Therapeutics|December 7, 2018
Body composition and sarcopenia: The next-generation of personalized oncology and pharmacology?Marc Hilmi, Anne Jouinot, Robert Burns, et al.
Pharmacology & Therapeutics|December 3, 2014
Targeting the TGFβ pathway for cancer therapyCindy Neuzillet, Annemilaï Tijeras-Raballand, Romain Cohen, et al.
Endocrine-Related Cancer|August 12, 2016
Pancreatic ductal adenocarcinoma in BRCA2 mutation carriersLouis de Mestier, Jean-Baptiste Danset, Cindy Neuzillet, et al.
The Journal of Biological Chemistry|August 18, 2006
Modulation of collagen and MMP-1 gene expression in fibroblasts by the immunosuppressive drug rapamycin. A direct role as an antifibrotic agent?Nicolas Poulalhon, Dominique Farge, Nina Roos, et al.
The Lancet. Gastroenterology & Hepatology|October 22, 2023
The immunological landscape in pancreatic ductal adenocarcinoma and overcoming resistance to immunotherapyMarc Hilmi, Matthieu Delaye, Milena Muzzolini, et al.
Bulletin Du Cancer|September 26, 2020
[Physical activity after breast cancer diagnosis and survival: A systematic review]Louise Maumy, Eleonora Salakos, Grégoire Rocher, et al.
Pageof 14

Showing results (41-50 of 138) with videos related to

Sort By:
Pageof 14
Clinics and Research in Hepatology and Gastroenterology|June 26, 2023
Nutrition support in pancreatic cancer: An expert statement on practical implementation of French guidelinesJulien Taieb, Raëf Abdallah, Ronan Thibault, et al.
Clinics and Research in Hepatology and Gastroenterology|February 19, 2021
Microbiome and pancreatic ductal adenocarcinomaAnnemilaï Tijeras-Raballand, Marc Hilmi, Lucile Astorgues-Xerri, et al.
Oncotarget|July 13, 2015
Targeting cancer cell metabolism in pancreatic adenocarcinomaRomain Cohen, Cindy Neuzillet, Annemilaï Tijeras-Raballand, et al.
Medicine|July 2, 2016
Severe hyponatremia caused by nab-paclitaxel-induced syndrome of inappropriate antidiuretic hormone secretion: A case report in a patient with metastatic pancreatic adenocarcinomaCindy Neuzillet, Samy Babai, Emmanuelle Kempf, et al.
Pharmacology & Therapeutics|December 7, 2018
Body composition and sarcopenia: The next-generation of personalized oncology and pharmacology?Marc Hilmi, Anne Jouinot, Robert Burns, et al.
Pharmacology & Therapeutics|December 3, 2014
Targeting the TGFβ pathway for cancer therapyCindy Neuzillet, Annemilaï Tijeras-Raballand, Romain Cohen, et al.
Endocrine-Related Cancer|August 12, 2016
Pancreatic ductal adenocarcinoma in BRCA2 mutation carriersLouis de Mestier, Jean-Baptiste Danset, Cindy Neuzillet, et al.
The Journal of Biological Chemistry|August 18, 2006
Modulation of collagen and MMP-1 gene expression in fibroblasts by the immunosuppressive drug rapamycin. A direct role as an antifibrotic agent?Nicolas Poulalhon, Dominique Farge, Nina Roos, et al.
The Lancet. Gastroenterology & Hepatology|October 22, 2023
The immunological landscape in pancreatic ductal adenocarcinoma and overcoming resistance to immunotherapyMarc Hilmi, Matthieu Delaye, Milena Muzzolini, et al.
Bulletin Du Cancer|September 26, 2020
[Physical activity after breast cancer diagnosis and survival: A systematic review]Louise Maumy, Eleonora Salakos, Grégoire Rocher, et al.
Pageof 14